Mark Seierstad

1.2k total citations
30 papers, 914 citations indexed

About

Mark Seierstad is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Seierstad has authored 30 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Seierstad's work include Cannabis and Cannabinoid Research (11 papers), Alcohol Consumption and Health Effects (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Mark Seierstad is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Alcohol Consumption and Health Effects (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Mark Seierstad collaborates with scholars based in United States, Belgium and Australia. Mark Seierstad's co-authors include J. Guy Breitenbucher, Dimitris K. Agrafiotis, Christopher J. Cramer, Christopher R. Kinsinger, Scott E. Denmark, Sandra R. Chaplan, Michael Webb, Brian Scott, John M. Keith and James A. Palmer and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Mark Seierstad

29 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Seierstad United States 17 317 305 252 172 114 30 914
Antonio Entrena Spain 21 165 0.5× 500 1.6× 703 2.8× 70 0.4× 47 0.4× 60 1.5k
Malliga R. Iyer United States 23 398 1.3× 426 1.4× 241 1.0× 385 2.2× 53 0.5× 63 1.3k
Jacques Joubert South Africa 20 292 0.9× 368 1.2× 611 2.4× 78 0.5× 44 0.4× 63 1.1k
Pier Vincenzo Plazzi Italy 22 456 1.4× 533 1.7× 585 2.3× 279 1.6× 13 0.1× 50 1.5k
Daniel‐Henri Caignard France 24 139 0.4× 666 2.2× 945 3.8× 216 1.3× 44 0.4× 62 1.6k
Christopher W. Cunningham United States 15 122 0.4× 251 0.8× 126 0.5× 234 1.4× 43 0.4× 36 636
Brian Scott United States 15 244 0.8× 337 1.1× 401 1.6× 160 0.9× 8 0.1× 24 1.0k
Pilar Goya Spain 24 778 2.5× 647 2.1× 678 2.7× 468 2.7× 21 0.2× 131 1.8k
Sándor Hosztafi Hungary 17 138 0.4× 471 1.5× 474 1.9× 354 2.1× 28 0.2× 108 1.2k
Timothy J. Hagen United States 23 359 1.1× 908 3.0× 655 2.6× 290 1.7× 20 0.2× 68 1.7k

Countries citing papers authored by Mark Seierstad

Since Specialization
Citations

This map shows the geographic impact of Mark Seierstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Seierstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Seierstad more than expected).

Fields of papers citing papers by Mark Seierstad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Seierstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Seierstad. The network helps show where Mark Seierstad may publish in the future.

Co-authorship network of co-authors of Mark Seierstad

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Seierstad. A scholar is included among the top collaborators of Mark Seierstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Seierstad. Mark Seierstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarver, Stefan J., Luke Elizabeth Hanna, Aaron A. Thompson, et al.. (2024). Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian Disruptions. ACS Medicinal Chemistry Letters. 15(4). 486–492. 1 indexed citations
2.
Ohadi, Donya, Kiran Kumar, Renée L. DesJarlais, et al.. (2024). Input Pose is Key to Performance of Free Energy Perturbation: Benchmarking with Monoacylglycerol Lipase. Journal of Chemical Information and Modeling. 64(23). 8859–8869. 2 indexed citations
3.
Yunhui, Ge, Vineet Pande, Mark Seierstad, & Kelly L. Damm‐Ganamet. (2024). Exploring the Application of SiteMap and Site Finder for Focused Cryptic Pocket Identification. The Journal of Physical Chemistry B. 128(26). 6233–6245. 6 indexed citations
4.
Seierstad, Mark, et al.. (2023). Convergent synthesis of thiodiazole dioxides from simple ketones and amines through an unusual nitrogen-migration mechanism. Chemical Science. 15(1). 328–335. 1 indexed citations
5.
Seierstad, Mark, Mark S. Tichenor, Renée L. DesJarlais, et al.. (2021). Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building Blocks. ACS Medicinal Chemistry Letters. 12(11). 1853–1860. 7 indexed citations
6.
Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2020). Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 30(20). 127463–127463. 4 indexed citations
7.
Savall, Brad M., Dongpei Wu, Devin M. Swanson, et al.. (2018). Discovery of Imidazo[1,2-a]pyrazines and Pyrazolo[1,5-c]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators. ACS Medicinal Chemistry Letters. 10(3). 267–272. 16 indexed citations
8.
Maher, Michael P., José A. Matta, Shenyan Gu, Mark Seierstad, & David S. Bredt. (2017). Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins. Neuron. 96(5). 989–1001. 51 indexed citations
9.
Keith, John M., Mark S. Tichenor, Richard L. Apodaca, et al.. (2016). The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(13). 3109–3114. 11 indexed citations
10.
Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2014). Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(3). 737–741. 24 indexed citations
11.
Keith, John M., Natalie A. Hawryluk, Richard L. Apodaca, et al.. (2014). 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(5). 1280–1284. 11 indexed citations
12.
Tichenor, Mark S., John M. Keith, W. M. Jones, et al.. (2012). Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites. Bioorganic & Medicinal Chemistry Letters. 22(24). 7357–7362. 20 indexed citations
13.
Swanson, Devin M., Jill A. Jablonowski, Chandra Shah, et al.. (2011). The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor. Bioorganic & Medicinal Chemistry Letters. 21(18). 5552–5556. 13 indexed citations
14.
Keith, John M., Richard L. Apodaca, Wei Xiao, et al.. (2008). Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 18(17). 4838–4843. 76 indexed citations
15.
Seierstad, Mark, Richard L. Apodaca, Sean M. Brown, et al.. (2008). Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters. 18(6). 2109–2113. 25 indexed citations
16.
Kuei, Chester, Steven W. Sutton, Pascal Bonaventure, et al.. (2007). R3(BΔ23–27)R/I5 Chimeric Peptide, a Selective Antagonist for GPCR135 and GPCR142 over Relaxin Receptor LGR7. Journal of Biological Chemistry. 282(35). 25425–25435. 116 indexed citations
17.
Keith, John M., Michael A. Letavic, Kiev S. Ly, et al.. (2006). Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore. Bioorganic & Medicinal Chemistry Letters. 17(3). 702–706.
18.
Seierstad, Mark & Dimitris K. Agrafiotis. (2006). A QSAR Model of hERG Binding Using a Large, Diverse, and Internally Consistent Training Set. Chemical Biology & Drug Design. 67(4). 284–296. 65 indexed citations
19.
Seierstad, Mark, Christopher R. Kinsinger, & Christopher J. Cramer. (2002). Design Optimization of 1,3-Diphospha-2,4-diboretane Diradicals. Angewandte Chemie International Edition. 41(20). 3894–3896. 56 indexed citations
20.
Seierstad, Mark, Christopher R. Kinsinger, & Christopher J. Cramer. (2002). Design Optimization of 1,3-Diphospha-2,4-diboretane Diradicals. Angewandte Chemie. 114(20). 4050–4052. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Entrena Breakdown of academic impact, for papers by Malliga R. Iyer Breakdown of academic impact, for papers by Jacques Joubert Breakdown of academic impact, for papers by Pier Vincenzo Plazzi Breakdown of academic impact, for papers by Daniel‐Henri Caignard Breakdown of academic impact, for papers by Christopher W. Cunningham Breakdown of academic impact, for papers by Brian Scott Breakdown of academic impact, for papers by Pilar Goya Breakdown of academic impact, for papers by Sándor Hosztafi Breakdown of academic impact, for papers by Timothy J. Hagen
Rankless by CCL
2026